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Background: Solar ultraviolet (UV) radiation has deleterious effects on the skin, including sunburn, photoaging and
cancer. Chocolate flavanols are naturally-occurring antioxidant and anti-inflammatory molecules that could play a
role in preventing cutaneous UV damage. We investigated the influence of 12-week high-flavanol chocolate (HFC)
consumption on skin sensitivity to UV radiation, measured by minimal erythema dose (MED). We also evaluated skin
elasticity and hydration.
Methods: In this 2-group, parallel, double-blind, randomized controlled trial, 74 women aged 20–65 years and
Fitzpatrick skin phototypes I or II were recruited from the general community in Quebec City, for randomization
to either HFC (n = 33) or low-flavanol chocolate (LFC) (n = 41). A blocked randomisation (4), considering date of entry,
skin type and age as factors, generated a sequentially-numbered allocation list. Study participants and research assistants
were blinded. Totally, 30 g of chocolate were consumed daily for 12 weeks, followed by a 3-week washout period. MED
was assessed at baseline and at 6, 9, 12 and 15 weeks. Main outcome was changes in MED at week 12.
Results: 33 participants in the HFC group and 41 in the LFC group were analyzed with 15 weeks of follow-up. Both
groups showed similarly-increased MED at 12 weeks (HFC: 0.0252 ± 0.1099 J/cm2 [mean ± standard deviation (SD)];
LFC: 0.0151 ± 0.1118; mean difference (MD): 0.0100 J/cm2; 95% confidence interval (CI): −0.0417 to 0.0618). However,
after 3-week washout, the HFC group presented decreased MED (−0.0248 ± 0.1145) whereas no effect was seen in
the LFC group (0.0168 ± 0.1698) (MD: −0.0417; 95% CI: −0.1106 to 0.0272). Net temple elasticity increased slightly but
significantly by 0.09 ± 0.12 mm in the HFC group at 12 weeks compared to 0.02 ± 0.12 mm in the LFC group (MD: 0.06;
95% CI: 0.01 to 0.12 ). No significant adverse events were reported.
Conclusion: Our study failed to demonstrate a statistically-significant protective effect of HFC vs. LFC consumption on
skin sensitivity to UV radiation as measured by MED.
Trial registration: ClinicalTrials.gov identifier: NCT01444625
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Associated with morphological and physiological changes,
aging of the skin is a complex process that reflects inevit-
able chronological aging accentuated by environmental fac-
tors. Although several genetic and environmental elements
interplay, the most well-understood mechanism by which
skin aging occurs is through chronic solar ultraviolet (UV)* Correspondence: sylvie.dodin@fmed.ulaval.ca
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unless otherwise stated.radiation, known as photoaging [1,2]. Indeed, chronic solar
UV exposure has multiple damaging effects, such as
wrinkling, dryness, dyspigmentation, epidermal thinning
and increasing fragility. Changes, especially in elastic fi-
bers of the dermis, result in loss of flexibility and tensile
strength, with collagen shortfall, inducing skin stiffness
[1]. UV radiation is one of the most ubiquitous carcino-
gens in our environment, and skin cancers represent one
of the major consequences of excessive exposure. In
addition, evidence is growing in support of the view that
UV levels are rising because of stratospheric ozone deple-
tion and climate change [3-6].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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defense against damaging environmental influences,
particularly sun exposure. The World Health Organization
recommends wearing protective c1othing, avoiding mid-
day sun and applying sunscreen. Yet, studies have dis-
closed that on sunny days no more than 65-67% of Danish
sunbathers use sunscreen at the beach, and only 46%
of sunscreen users applied it all over their body [7]. In
a Canadian study, 40% to 48% of individuals reported
practising protective behaviours, such as applying sun-
screen to the body, wearing protective clothing, seek-
ing shade and avoiding the sun between 11 am and
4 pm [8].
The concept of photoprotection by dietary means is
gaining momentum, and interest is growing in natural
dietary polyphenols for the prevention of UV-induced
damage [2,7,9]. Flavanols, a subclass of polyphenols, pos-
sess efficient antioxidant [10-14] and anti-inflammatory
[15-20] properties. Recent but scarce data indicate
that chronic ingestion of high-flavanol cocoa might
be a promising approach to dietary photoprotection
against UV light. [21-23] Furthermore, flavanol-rich
cocoa intake has been shown to increase microcircula-
tion in human skin [24]. Nutritional photoprotection
with flavanol-rich chocolate is a promising area for re-
search, but double-blind clinical trials are required to
confirm experimental findings.
As flavanols exert antioxidant, anti-inflammatory and
anti-DNA-damaging effects that may enhance the skin’s
microcirculation, we hypothesized that chronic flavanol-
rich chocolate consumption may represent an effective
strategy to protect against harmful UV radiation.
Our study’s primary objective was to investigate the
impact of 12-week high-flavanol chocolate (HFC) con-
sumption vs. LFC on skin sensitivity to UV radiation,
measured by minimal erythema dose (MED). Its second-
ary objectives were to assess the effects of HFC vs. LFC




We undertook a 2-group, parallel, double-blind, ran-
domized clinical trial (RCT) with a 3-week washout
period.
Ethics statement
The protocol and consent form for this study were ap-
proved by the institutional health science research ethics
committee of Université Laval, Quebec. Appointments
were scheduled for eligible women, where the risks and
benefits of their possible participation were reviewed in
detail. The informed consent form was read and signed
by them before study inclusion.Study participants
Between July 2011 and March 2012, we enrolled non-
smoking healthy women aged 20 to 65 years who had nor-
mal skin types I or II, as described by Fitzpatrick [25].
We excluded patients with one or more of the following
conditions: pregnancy or breast- feeding, photosensitivity,
history of skin cancer, photosensitizing medication, sunbed
tanning or sunbathing in preceding 3 months, planned
sunbed tanning or sunbathing during the study period,
supplements of any kind (fish oil, coenzyme Q-10, garlic,
lycopene, beta-carotene, etc.), except for medically-
prescribed supplements or natural health products,
consumption of ≥2 alcoholic drinks per day, allergy
or intolerance to nuts or chocolate, body mass index
(BMI) >35, hormone replacement therapy (HRT) or hor-
monal contraception in the preceding 6 months before
the pre-randomization visit, or planned HRT or hormo-
nal contraception during the study period. Women with
systolic blood pressure ≥160 mmHg, diastolic blood pres-
sure ≥100 mmHg, or treated with antihypertensive medi-
cation(s) were also excluded.
Recruitment and randomization
Women were recruited from the general population of
Quebec City through websites, email, newspapers, radio-
television advertising, and flyers posted in clinics. Poten-
tial study participants in the study contacted the study
coordinator who explained the research project to them
and verified inclusion and exclusion criteria.
Allocating participants to trial groups
At the randomization visit, participants were randomly
assigned to either HFC (experimental group) or low-
flavanol chocolate (LFC, placebo group). The randomi-
zation schedule was prepared at the St-François d'Assise
Research Centre statistics unit. A blocked randomisation
(4) was computer-generated by a statistician who was not
involved in the study. It was stratified according to skin
type (I and II) and age (30–35 years; 36–49 years; 50–65
years). A first list of randomisation was generated accord-
ing to an equal number of participants in each age and skin
type stratum. After three months of recruitment, propor-
tion of women with skin type 2 and age 50–65 were more
prevalent than expected and a new independent list of ran-
domisation was generated.
Intervention
Daily chocolate intake (30 g)
Study participants consumed 1 chocolate square 3 times
per day (30 g/day) for 12 weeks, included in participants’
regular diet in place of an equivalent food in terms of
energy and macronutrient content. The nutritional con-
tents of each HFC and LFC square (10 g) are presented
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flavanols daily.
HFC and LFC were supplied as chocolate bars by
Barry-Callebaut, Lebeke-Wieze, Belgium. All steps of
chocolate production (fermentation, drying, roasting,
and alkalinization) were optimized to preserve antioxi-
dants. Chocolate bars were standardized for their flava-
nol and theobromine content and matched for caloric
load, nutrients and caffeine. They were similar in taste
and colour and were supplied in individual, opaque
packaging. 30 g of chocolate contained less than 25 mg
of caffeine.
Measurements
Recruited participants presented at the Institute of
Nutrition and Functional Foods (INAF) clinical facility for
a total of 10 visits, including 5 10-minute visits 24 hours
after each main visit, for MED assessment.
Participants were asked to abstain from chocolate con-
sumption, other than the study product, for the study’s
duration, including the washout period, and for 7 days
before the randomization visit. Intense physical activity
was forbidden for 48 hours preceding each visit. Women
could not apply any body lotion, gel or moisturizer on
the skin for the 24 hours preceding each visit.
Baseline
A short questionnaire documenting social and demo-
graphic characteristics, alcohol consumption, and medi-
cation, was completed by participants. Anthropometric
data (body weight, height and body fat percentage) were
measured according to a standard protocol. [26] Food
habits and f1avonoid consumption during the last
month were estimated by validated food frequency
questionnaire (FFQ) [27]. Sun exposure (>30 minutes
daily) and sun protection practices during the last sum-
mer and last week were evaluated by validated auto-
administered questionnaire [28]. Blood samples were
collected. MED and skin elasticity were measured, as
were hydration parameters.
Follow-up visits
Participants returned to our clinical research facility for
follow-up visits at weeks 6, 9, and 12. All measurements
at the 12th week visit were repeated after a 3-week wash-
out period (15th week visit). MED, skin elasticity and hy-
dration parameters were tested during each follow-up
visit. Anthropometric data were collected. Blood samples
were taken at every visit, in the morning after over-
night fasting except for their morning 10-g intake of
chocolate, for measurement of plasma flavanols and meth-
ylxanthines. Blood pressure was measured at every visit.
Participants completed the FFQ to estimate their food con-
sumption in the last month. Sun exposure and protectionpractices during the previous week were evaluated.
Women returned 24 hours later for a 15-minute visit to
assess the MED results.
Evaluation of side-effects
BMI (kg/m2) and body fatness were assessed by bio-
electrical impedance according to the validated Tanita
technique. [26] Digestive and other symptoms (nausea,
abdominal pain, constipation, and headache) were docu-
mented by questionnaire administered at randomization
and at each study visit. Blood lipid profile and glucose




Defined as the lowest UV dose to elicit just perceptible
erythema at 24 hours, MED was assessed by an auto-
matic Durham erythema dose tester emitting narrow-
band ultraviolet B (UVB) light (emission peak 311 nm).
This valid and reproducible method [29] involves a small
hand-held unit containing low-pressure TL-01 tubes and
a 10-aperture plate with metal foil attenuators designed
to administer a 1.26 dose series (i.e. dose increments of
1.26 times the previous dose). The time period of MED
tester application on the skin, corresponding to max-
imum dosage at open aperture, was determined by pa-
tients’ Fitzpatrick skin type. The attenuation factor of
other apertures produced a dose sequence, with each
subsequent hole receiving a smaller dose than the previ-
ous one. The test device was switched on for 10 minutes
to reach optimum performance. After 10 minutes, the
unit was switched off, and the test commenced immedi-
ately. Exposure time listed on previously-selected dosage
was set and the device placed on a forearm (the same
side was then used for all subsequent measures). The
timer and tester were switched on simultaneously, and
good skin contact was maintained. When the alarm
sounded, the tester was switched off. All tests on each
patient were performed at the same vertical level. MED
was evaluated clinically under controlled, artificial light-
ing by determining which aperture presented just per-
ceptible erythema 24 hours after irradiation, in accordance
with a validated method for MED testing with the Durham
erythema dose system [30-34].
Skin elasticity parameters
Skin parameters were assessed by Cutometer (MPA580,
Courage & Khazaka, Cologne, Germany) [35]. Measure-
ments were based on the suction method. Negative pres-
sure was created in the device, and skin was drawn into
the probe’s aperture. Penetration depth was ascertained
by a non-contact optical system consisting of a light
source and light receiver as well as 2 prisms facing each
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Light intensity varied with penetration depth. With larger
probe apertures, deeper layers of the skin are deformed by
suction. We, therefore, chose an 8-mm aperture. The re-
sistance of skin sucked up by negative pressure (firmness)
and its ability to return to its original position (elasticity)
were displayed as curves at the end of each measurement.
The cutometer generated a graph (Additional file 1:
Figure S1) depicting immediate deformation or skin ex-
tensibility (Ue), delayed distention (Uv), final deform-
ation (Uf) and immediate retraction (Ur). Ur/Ue ratio, or
net elasticity, was the parameter of choice for quantifying
skin aging, since it represented the ability of skin to re-
cover after deformation. This parameter is independ-
ent of skin thickness. We evaluated final skin distension
(distensibility), overall elasticity and net e1asticity [36].
Before skin measurement, the participants remained in
a seated position for 10 minutes, in an environmentally-
controlled room (temperature: 22 ± 2°C, relative humid-
ity: 40-60%), for acclimatization to ambient conditions.
Skin hydration parameters
The CM 825 Corneometer (Courage & Khazaka, Co-
logne, Germany), a well-established and accurate system,
estimated skin surface hydration level. It is principally
based on capacitance measurement of dielectric media.
Changes in the dielectric constant due to variation of
skin surface hydration alter capacitance of the precision-
measuring capacitor. Reproducibility of the instrument
is high (coefficient of variation ± 3%). Measurement time
is about 1 second. Even slight modifications of hydration
level can be detected [37].
Plasma flavanols and methylxanthines concentrations
Flavanols were measured in the INAF laboratory by
P. Dubé. They were purified by solid extraction, followed
by high-pressure liquid chromatography with a fluores-
cence detection system [38]. Methylxanthines were quanti-
fied by high-pressure liquid chromatography [39].
Compliance
Study participants received a telephone reminder in the
week preceding each visit. To promote chocolate com-
pliance, the research coordinator telephoned them a few
days before each study visit. A new appointment was
scheduled if participants missed a visit. In addition, they
documented their daily intake of chocolate bars on
diary cards. Plasma theobromine concentrations served as
marker of cocoa consumption [40].
Blinding and methods for protecting against sources
of bias
All clinical, biophysical, laboratory and statistical analyses
were blinded. We applied the intent-to-treat principle toavoid attrition bias. Participants were compared in the
groups to which they were originally assigned randomly.
According to previous experience, we anticipated that 15%
of randomized women would be lost to follow-up. To en-
sure support and motivation for substitution of equivalent
foods by chocolate, participants received nutritional coun-
selling at the randomization and 6th week visits. All efforts
were made to ensure primary outcome (MED) measure-
ments at the 6th, 9th, 12th and 15th week visits in all ran-
domized patients.
To avoid selection bias, the study subjects, investiga-
tors, staff and all laboratory analyses were blinded to
treatment assignment. All chocolate bars were matched
for calorie load, nutrients and caffeine. Similar in ap-
pearance (e.g. colour and quantity), smell and taste, they
were supplied in individual, opaque packaging. The pro-
portion of women who guessed right about group alloca-
tion was documented with a short questionnaire at the
15th week visit.
To control for contamination bias, flavonoid con-
sumption was measured by FFQ in the last month
preceding each follow-up visit. Finally, data were collected
according to a standardized procedure supervised by the
research coordinator who had extensive experience in data
monitoring. Sunbathing and tanning devices were not per-
mitted during the study period.
Sample size and planned recruitment rate
Williams et al. [12] reported MED mean ± standard error
of the mean of 0.l09 ± 0.011 J/cm2 in a sample of healthy
subjects, which rose to 0.223 ± 0.019 after 12-week choc-
olate intake. Based on these estimates, with standard
deviation (SD) of 0.043, a sample of 31 women was re-
quired in each group to detect a minimal difference of
0.031 (28%) between groups with 5% 2-sided significance
and 80% power. 15% loss to follow-up was anticipated so
that sample size was increased to a total of 73 women.
Augmenting it to 74 allowed equal numbers of subjects
in both study arms.
Statistical analysis
Statistical data analysis investigated the effect of HFC vs.
LFC consumption on skin sensitivity to UV radiation ac-
cording to MED criteria. Thus, the statistical hypothesis
was that mean MED was not different in those who con-
sumed HFC and those who did not: null hypothesis
(H0): mean difference (MD) = 0. Statistical analysis was
carried out at the St-François d'Assise Hospital Research
Centre, CHUQ, with SAS software (version 9.3), accord-
ing to the intent-to-treat principle. P values (bilateral)
lower than or equal to 0.05 indicated significant differ-
ences. The baseline characteristics of participants in each
group were compared by Chi-square test for categorical
variables and independent sample t-test for continuous
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the randomization process. The primary outcome was
changes in MED values, calculated as the difference for
each person at weeks 6, 9 and 12 compared to baseline.
MED at 15 weeks was compared to week 12. The sec-
ondary endpoints were assessed similarly. The primary
outcome was analyzed in secondary analysis of repeated
measures adjusted for potential factors affecting MED.
Differences in the number and quality of side-effects be-
tween the 2 groups were compared as well.
The results were expressed as means ± SD at baseline
and at 6, 9, 12 and 15 weeks; n was number of women.
Missing data were imputed by a commonly-employed
single imputation method with null values for mean dif-
ferences. We explored different approaches to the im-
putation problem. All analyses are in general agreement
qualitatively, and intent-to-treat results are presented.
Multivariate analysis included baseline values for each
outcome, Fitzpatrick skin phototype (I or II), season
of study participation, age of participants (<50 years
or ≥50 years), and BMI (for the skin hydration outcome
only), as potential confounding variables. In the final
multivariate model, baseline values for each analyzed out-
come, season of study participation, age of participants
(<50 years or ≥50 years), and BMI (for the skin hydration
outcome only) were retained by backward step-wise elim-
ination. If, by removing a variable from the model,
change in the regression coefficient was more than 10%
compared to the adjusted model including all variables,
then that variable was retained in the final model. Skin
phototype was not specifically accounted for in the final
model for primary outcome since more precise measure-
ment of skin photosensitivity was included in the form of
MED values at baseline.
Results
For each group, Figure 1 shows the number of partici-
pants who were excluded before randomization, or were
randomly assigned, received intended treatment or were
lost after randomization with reasons, and were analyzed
for primary and secondary outcomes.
Of the 74 randomized study participants, 59 (27 and
32 in the HFC and LFC arms, respectively) had out-
comes available for analysis per protocol. Intent-to-treat
analysis was conducted as described above. 7 and 9
women respectively were lost to follow-up for reasons
not related to the intervention.
At randomization, the 2 arms were well balanced
with regard to social and baseline characteristics, ex-
cluding BMI which was 1.8 higher in the LFC group
and season at week 12. Specifically, the percentage of
participants in the HFC group who were evaluated
before the spring season was lower than in the LFC
group (Table 1).Primary outcome
Minimal erythema dose
Table 2 reports that HFC consumption had no effect on
MED at 6, 9 and 12 weeks in comparison to control
LFC. After the 3-week washout period, MED in the HFC
group receded to baseline. On the other hand, MED in
the LFC arm continued to increase. Figure 2 illustrates
the tendency of mean MED differences after daily con-
sumption of 30 g chocolate. The nearly parallel curves
for both groups up to week 12 illustrated the absence of
a significant difference in MED at this time-point. How-
ever, both groups went in opposite directions, starting
from the washout period.
Multivariate analysis for adjusted changes in MED at
6, 9 and 12 weeks gave findings similar to those with
univariate analysis. Conversely, the difference between
adjusted changes in MED after the washout period in
the HFC arm was −0.07 higher and in the opposite direc-
tion compared to the LFC group (MD= −0.07; 95% confi-
dence interval (CI): −0.13 to −0.01; P = 0.01; R2 = 0.46)
(Additional file 1: Table S1), thus becoming statistically sig-
nificant. Age ≥50 years was associated with greater changes
in MED at 12 and 15 weeks, and spring season of evalu-
ation was linked with lesser changes in MED at 12 and
15 weeks (Additional file 1: Table S2).
Secondary endpoints
Skin hydration and elasticity parameters
Overall temple elasticity increased slightly but signifi-
cantly: 0.05 ± 0.09 mm in the HFC group at 6 weeks
compared to LFC (P = 0.04) (Table 3). Net temple elasti-
city also increased slightly but significantly: 0.08 ± 0.08
and 0.09 ± 0.12 mm in the HFC group at 6 and 12 weeks,
respectively, compared to LFC (P = 0.01 and P = 0.03, re-
spectively) (Table 4). No other significant between-group
changes were observed (Tables 3 and 4 and Additional
file 1: Tables S8 and S9).
Multivariate analysis of adjusted changes in skin hydra-
tion and elasticity parameters at 6, 9 and 12 weeks, and
after 3-week washout gave results comparable to those of
univariate analysis (Additional file 1: Tables S3-S6).
Plasma polyphenol concentrations
Plasma polyphenol concentrations were similar in both
groups at baseline. The LFC group presented clinically
small but statistically significant increases in plasma epi-
catechins at weeks 6, 9 and 12 compared to baseline
(P < 0.0001). In the HFC group, marked increments in
plasma epicatechin concentrations were clinically and
statistically significant (P < 0.0001) compared to base-
line at weeks 6, 9, and 12. However, plasma concentra-
tion at week 12 was lower than at week 6. Changes in
plasma epicatechin concentrations in the HFC group
were statistically higher than in the LFC group at all
Figure 1 Flow diagram of study participation. *1 participant withdrew voluntarily from the study at week 9, but accepted to return
at week 12.
Mogollon et al. Nutrition Journal 2014, 13:66 Page 6 of 12
http://www.nutritionj.com/content/13/1/66
Table 1 Baseline and demographic characteristics
Clinical characteristics High-flavanol
chocolate (n = 33)
Low-flavanol
chocolate (n = 41)
MED (J/cm2) 0.56 ± 0.14 0.61 ± 0.17
Skin type˦ I 15 (45.5) 16 (39.0)
II 18 (54.5) 25 (61.0)
Season at week 12˦
Before April 15 10 (30.3) 17 (41.5)
After April 15 23 (69.7) 24 (58.5)
Overall skin elasticity (mm)
Arm 0.76 ± 0.08 0.76 ± 0.09
Temple 0.54 ± 0.11 0.55 ± 0.10
Skin hydration (units**)
Arm 33.34 ± 7.27 33.05 ± 6.76
Temple 41.00 ± 13.02 42.39 ± 10.71
Plasma polyphenol
concentrations
Epicatechins (ng/ml) 0.12 ± 0.48 0.11 ± 0.43
Catechins (ng/ml) 0.20 ± 0.67 0.17 ± 0.64
Dietary polyphenol
consumption*
Epicatechins (mg/day) 10.50 ± 7.54 10.65 ± 7.00
Catechins (mg/day) 11.94 ± 7.91 14.35 ± 9.28
Age (years) 39.7 ± 14.2 39.3 ± 12.0
20 to 35˦ 15 (45.5) 19 (46.3)
36 to 49˦ 8 (24.2) 12 (29.3)
50 to 65˦ 10 (30.3) 10 (24.4)
Sun exposure habits˦
UV exposure (>30 minutes daily):
Weekdays 23 (69.7) 30 (73.2)
Weekend days 31 (93.9) 39 (95.1)
Painful sunburn 23 (69.7) 28 (68.3)
Educational attainment˦
University degree 24 (72.7) 36 (87.8)
Some university or college
education
9 (27.3) 5 (12.2)
Anthropometric measures
BMI (kg/m2) 22.6 ± 2.2 24.4 ± 3.6
**Arbitrary Corneometer® units. Values represent means ± SD.
*Polyphenol consumption was calculated by FFQ.
˦Values represent number and percentage.
Table 2 MED after daily consumption of 30 g chocolate











Baseline 0.56 ± 0.14 0.61 ± 0.17 -
Week 6 0.59 ± 0.17 0.61 ± 0.15 0.36
Week 9 0.58 ± 0.15 0.63 ± 0.18 0.86
Week 12 0.58 ± 0.14 0.62 ± 0.18 0.70
P value (Week 6
vs. Baseline)
0.24 0.96
P value (Week 9
vs. Baseline)
0.29 0.36




Week 15 0.56 ± 0.14 0.64 ± 0.18 0.21
P value (Week 15
vs.Week 12)
0.22 0.53
Values represent means ± SD.
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plasma catechins tended to be similar (Additional file 1:
Table S10).
Plasma methylxanthine concentrations
Plasma theobromine, theophylline and caffeine concen-
trations increased in both groups at weeks 6, 9 and 12versus baseline. However, no difference was found in
changes of plasma methylxanthine concentrations be-
tween the HFC and LFC groups at all measurement times
(Additional file 1: Table S11).
Consumption of dietary polyphenols
Consumption of dietary polyphenols was similar be-
tween both groups at baseline. During the study period,
both groups tended towards decreased dietary polyphe-
nols (not including interventional chocolate consump-
tion). No differences were evident in changes of dietary
polyphenol consumption between the HFC and the LFC
groups (Additional file 1: Table S12).
Washout period
Skin distensibility decreased slightly but significantly
(−0.02 ± 0.03 mm) in the HFC group at 15 weeks after
washout compared to LFC (P = 0.04) (Additional file 1:
Table S13). Plasma polyphenol concentrations returned
to baseline after the washout period in both groups. This
change was statistically different when both groups were
compared (P < 0.0001 and P = 0.0005 for epicatechins
and catechins, respectively) (Additional file 1: Table S14).
Plasma methylxanthine concentrations decreased to base-
line after 3-week washout. The change was not statistically
different between the 2 groups (P = 0.07, P = 0.69 and
P = 0.10 for theobromine, theophylline and caffeine,
respectively) (Additional file 1: Table S15). No other signifi-
cant between-group differences were observed in skin hy-
dration and dietary polyphenol consumption during the
washout period (Additional file 1: Tables S16 and S17).
Baseline Week 6 Week 9 Week 12 Week 15
Chocolate 0 0,0288 0,0185 0,0252 -0,0248


















Figure 2 Mean MED differences within treatments. *Changes in MED corresponded to differences between the endpoints evaluated (6, 9, 12
and 15 weeks) and baseline (J/cm2).
Table 3 Overall skin elasticity after daily consumption of












Baseline 0.76 ± 0.08 0.76 ± 0.09 -
Week 6 0.76 ± 0.09 0.75 ± 0.06 0.61
Week 9 0.77 ± 0.08 0.76 ± 0.07 0.48
Week 12 0.76 ± 0.10 0.75 ± 0.08 0.42
P value (Week 6
vs Baseline)
0.97 0.51
P value (Week 9
vs Baseline)
0.29 0.95




Baseline 0.54 ± 0.11 0.55 ± 0.10 -
Week 6 0.59 ± 0.09 0.55 ± 0.10 0.04
Week 9 0.55 ± 0.12 0.56 ± 0.10 0.64
Week 12 0.60 ± 0.12 0.57 ± 0.11 0.10
P value (Week 6
vs Baseline)
0.0024 0.92
P value (Week 9
vs Baseline)
0.33 0.81
P value (Week 12
vs Baseline)
0.0016 0.10
Values represent means ± SD.
Values in bold are statistically significant.
Table 4 Net skin elasticity after daily consumption of











Baseline 0.73 ± 0.19 0.75 ± 0.20 -
Week 6 0.75 ± 0.18 0.78 ± 0.20 0.52
Week 9 0.77 ± 0.21 0.81 ± 0.22 0.49
Week 12 0.81 ± 0.22 0.80 ± 0.23 0.54
P value (Week 6
vs Baseline)
0.50 0.12
P value (Week 9
vs Baseline)
0.07 0.01




Baseline 0.43 ± 0.14 0.45 ± 0.13 -
Week 6 0.51 ± 0.15 0.47 ± 0.13 0.01
Week 9 0.48 ± 0.17 0.47 ± 0.13 0.41
Week 12 0.52 ± 0.19 0.48 ± 0.12 0.03
P value (Week 6
vs Baseline)
<.0001 0.12
P value (Week 9
vs baseline)
0.02 0.38
P value (Week 12
vs Baseline)
0.0002 0.21
Values represent means ± SD.
Values in bold are statistically significant.
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As UV radiation accelerates skin aging and promotes
skin cancer, novel photoprotective measures represent a
promising area of research. Dietary polyphenols are nat-
ural antioxidant and anti-inflammatory agents that could
protect skin against UV exposure. In our population of
healthy non-smoking women, 12-week HFC intake was
associated with significantly increased net skin elasticity
but no significant change in MED. Participants did not
report any significant clinical side-effects.
The current literature suggests that chronic ingestion
of HFC may be photoprotective, but there are several
methodological limitations. Only 1 controlled, double-
blind, RCT evaluated the effect of HFC vs. LFC intake
on skin sensitivity to UV radiation after 12 weeks, as
measured by MED [23]. 22 women and 8 men with
Fitzpatrick skin phototypes II or III were included in
that trial. After 12 weeks, mean MED remained stable
in the LFC group compared to baseline. Statistically
significant increases in mean MED were observed with
HFC (within-group comparisons). Nevertheless, these
authors did not report between-group comparisons.
Moreover, women and men were included in their trial,
but participants’ characteristics in each group were not
elaborated. Finally, our study population was quite dif-
ferent from that of Williams’ [23] as we included only
women with skin type I or II.
Heinrich et al. enrolled 24 women in their RCT and
evaluated the effect of HFC vs. LFC intake on MED in
solar simulation radiation [21]. After 12 weeks, women
assigned to the HFC group showed significantly increased
MED in comparison to the LFC group. It is important to
note that the characteristics of women in each group were
not presented, and no information was given regarding
trial profile (loss-to-follow-up, intent-to-treat analysis). Fi-
nally, visually-assessed MED, considered to be the gold
standard [41], was not available. Thus, direct comparison
with other studies was not possible.
Several factors could have contributed to our finding
of no statistically photoprotective effects of HFC vs. LFC
measured by MED at 12 weeks. Season of participation
differed in the 2 groups. Specifically, more participants
in the LFC group started the trial during winter and fin-
ished at the 12-week endpoint during the spring season,
potentially introducing a residual confounding effect.
During this period, physiologically-increased MED is at-
tributed to longer solar exposure [42,43]. Indeed, ex-
ploratory analyses of our data demonstrated a boost in
MED during spring, compared to its stability during
winter and, inversely, a decrease during fall (Additional
file 1: Figure S2). This extrinsic effect could partly ex-
plain the shape of the LFC group curve in Figure 2, in
which it can be seen that MED increased from baseline
to week 12. Consequently, the increment could havemasked difference from the HFC group. Differing season
of participation could also have introduced bias in the re-
sults, since roughly one-third of participants in each group
completed the study during spring, when the natural in-
crease in MED could have rendered the photoprotective
effects of chocolate less visible. Indeed, multivariate
analyses revealed that HFC group participants terminat-
ing during spring manifested lower changes in MED.
Furthermore, it would have been interesting to study
women over the age of 50 years, as our multivariate ana-
lyses disclosed greater changes in MED in this population,
indicating that HFC may have significant photoprotective
effects after menopause in comparison to control LFC.
Finally, MED imbalance at baseline rendered our groups
less comparable, which we might not have completely
accounted for despite adjustments in our multivariate
model.
Lack of compliance with chocolate consumption is an-
other factor that could partially explain our non-significant
results. In fact, the HFC group showed a stronger increase
in MED at week 6 than at weeks 9 and 12 compared to
baseline, mimicking the same tendency found in plasma
polyphenol concentrations at these time periods. Women
could have been slightly less compliant with chocolate con-
sumption after 6 weeks, rendering its effects even less
noticeable.
It would have been interesting to compare HFC with
LFC low in theobromine, the primary alkaloid in cocoa.
Theobromine concentrations in our LFC and HFC
groups were similar. Although it has never been studied
extensively in humans, sparse data indicate that it has
been tested for the treatment of hypertension to exploit
its vasodilator and smooth tissue-relaxing properties
[44,45]. Theobromine may contribute to the effect of
dark chocolate on endothelium function. Therefore, it
could have increased the microcirculatory delivery of
flavanols in both groups (as the LFC group also showed
significant flavanol elevation), and masked the isolated
action of polyphenols.
Moreover, since MED was highly variable between
women participating in our clinical trial (as relative SD
was 25%), the non-optimal power of our study sample
could partially explain the non-significant results. Fur-
thermore, the variability of our results is highlighted by
the large CIs revealed by multivariate analysis. In addition,
it’s not possible to exclude that imbalance in numbers allo-
cated to HFC and LFC partly explained by the 2 inde-
pendently generated randomisation lists and differences
between the 2 groups for skin type and date of entry
could somewhat bias our results. Indeed, as specified in
the section methods, after three months of recruitment,
proportion of women with skin type 2 and age 50–65
were more prevalent than expected and a new inde-
pendent list of randomisation was generated. Moreover,
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Interestingly, after 3-week washout, the HFC group
showed decreased MED with return to baseline. Con-
versely, the LFC group manifested continuously elevated
MED. We would, therefore, have expected similar incre-
ment in the HFC group, instead of the observed decline.
This differential tendency after removal of our interven-
tion, well-illustrated in Figure 2, indicates loss of a clin-
ical effect too small to be statistically significant due
to the afore-mentioned factors contributing to lack of
significance.
MED represents the lowest UV dose necessary to pro-
duce just perceptible erythema at 24 hours. The ery-
thema reaction to UV is the endpoint of complex
biological processes, including direct DNA, lipid and
protein damage, activation of pro-inflammatory path-
ways and generation of free radicals, mainly reactive
oxygen species. Polyphenols are expected to act mainly
on the latter by supplementing the body’s natural, free-
radical-quenching, antioxidant mechanisms [10-14] . A
recently-published review [46] of photoprotection and
antioxidants notes that the action spectrum of reactive
oxygen species generation is predominately in the ultra-
violet A (UVA) range, although there is some overlap
with UVB. Thus, perhaps antioxidants play a larger role
in protecting against UVA-induced production of free
radicals. Consequently, measurement of the photopro-
tective effects of flavanols solely by MED after exposure
to UVB might not be fully representative of their real
biological potential in this regard [46].
A positive outcome of HFC consumption was noted in
net temple elasticity at 12 weeks compared to LFC, but
was not reproduced in arm elasticity, suggesting that fla-
vanols might impact only sun-exposed skin for this out-
come. Furthermore, the gain in elasticity was not lost
after 3-week washout. The underlying mechanisms are
not known, but augmented blood flow [24] can lead to
heightened production of collagen and elastin, key struc-
tural proteins which diminish in the skin with aging. On
the other hand, HFC consumption did not modify skin
hydration. Heinrich et al. postulated improvements in
skin density and thickness, stratum corneum hydration,
transepidermal water loss, and skin surface roughness
after 12 weeks of flavanol-rich cocoa drink consumption
in healthy women [21].
HFC and LFC consumption did not significantly change
BMI and blood glucose, a previously-reported finding [47].
Lipid profile also was not affected, except for a slight but
significant rise in high-density lipoprotein-cholesterol level
in the HFC compared to the LFC group at week 12. Partic-
ipants did not report any significant clinical side-effects. In
all, chocolate consumption did not result in notable ad-
verse events.Conclusion
We believe that additional clinical trials are needed to
fully evaluate the photoprotection conferred by HFC
consumption. Exploration of this association by our
study highlights the importance of sufficient sample
size in the context of great inter-individual variability in
skin sensitivity to UV, and perhaps the use of solar simu-
lators to more accurately assess the protective effects of
flavanols. In addition, all participants should be random-
ized according to MED to render groups comparable,
and evaluated in a single season. Flavanol effects could
also be explored in women after menopause. Finally, the
effect of HFC consumption compared with no (or usual/
discretionary) chocolate consumption on MED remains
to be addressed.
Additional file
Additional file 1: Chocolate flavanols and skin photoprotection: a
parallel, double-blind, randomized clinical trial.
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